Management of Elevated Tacrolimus Level in Dual Transplant Patient on Ciprofloxacin

Understanding the Drug Interaction

Ciprofloxacin inhibits CYP3A4-mediated metabolism of tacrolimus, leading to elevated blood levels, according to the American Journal of Transplantation 1
The target range for stable patients beyond the first year is 4-6 ng/mL for monotherapy or 3-5 ng/mL with combination immunosuppression, as recommended by the Journal of Hepatology 2, 3
Early post-transplant targets are only 5-15 ng/mL initially, then 5 ng/mL after one year, as stated by the American Journal of Transplantation 4, 5

Recheck tacrolimus level in 24-48 hours after adjustment, as suggested by Praxis Medical Insights 1
Assess renal function immediately by checking serum creatinine and comparing to baseline, according to Praxis Medical Insights 3, 6
Evaluate for neurotoxicity, including tremors, headaches, confusion, and seizures, as recommended by the American Journal of Transplantation 4, 5

Reduce tacrolimus dose to achieve target 4-6 ng/mL during ciprofloxacin course, as recommended by the Journal of Hepatology 2, 3
Monitor levels every 2-3 days during ciprofloxacin course, as suggested by Praxis Medical Insights 1
Anticipate the need to increase tacrolimus dose back toward pre-ciprofloxacin baseline after completing antibiotics, according to Praxis Medical Insights 1

Monitor complete blood count for bone marrow suppression if on mycophenolate, as recommended by the American Journal of Transplantation 5
Monitor blood glucose, as tacrolimus increases diabetes risk, according to the American Journal of Transplantation 4, 5
Monitor blood pressure, as both tacrolimus and ciprofloxacin can cause hypertension, as stated by the American Journal of Transplantation 4, 5
Monitor liver function tests, given liver transplant status, as recommended by the American Journal of Transplantation 5